Del Bigtree tells Mike Adams: The only way the pandemic can end now is through natural infection – Brighteon.TV

Informed Action Consent Network (ICAN) founder Del Bigtree tells Health Ranger Mike Adams that the only way the Wuhan coronavirus (COVID-19) pandemic can end now is through natural infection.

“At the very least, we’ve got to make the United States of America and our health department recognize what we’ve always known, which is natural infection leads to the most robust immunity there is,” says Bigtree during the “Health Ranger Report with Mike Adams” program on Brighteon.TV.

Bigtree laments the fact that White House coronavirus adviser Dr. Anthony Fauci, the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) are still refusing to acknowledge the value of natural immunity. (Related: Policymakers ignoring natural immunity to covid in favor of “vaccine” immunity.)

“We’ve got to change that,” he says, noting that the vaccine has proven to be a complete failure.

Studies show COVID-19 recovered patients retain broad and durable immunity to the disease

An Emory University study published in the journal Cell Reports Medicine has found that most people who have recovered from COVID-19 retain a broad and durable immunity to the disease, including some degree of protection against its variants.

After people recover from infection with a virus, the immune system retains a memory of it. Immune cells and proteins that circulate in the body can recognize and kill the pathogen if it’s encountered again, protecting against disease and reducing illness severity.

The study involved 254 COVID-19 patients between 18 to 82 years old, who provided blood samples at various points for a period of over eight months beginning April last year. About 71 percent of the patients had mild disease, 24 percent experienced moderate illness, and five percent had severe disease.

The researchers have found that most of the patients who recovered mounted a strong and wide-ranging immune response to the virus for at least the 250-day duration of the study.

COVID-19 recovered patients also displayed stable antibody responses to the other human coronaviruses that cause the common cold, the Middle East Respiratory Syndrome (MERS) or the Severe Acute Respiratory Syndrome (SARS).

A study funded in part by the National Institute of Allergy and Infectious Diseases (NIAID), of which Fauci is the director, has also found durable immune responses in the majority of people who had been exposed to SARS-CoV-2 and recovered.

The study published on Jan. 6 in Science analyzed immune cells and antibodies from almost 200 participants. Time since infection ranged from six days after symptom onset to eight months later. More than 40 participants had been recovered for more than six months before the study began. About 50 people provided blood samples at more than one time after infection.

Antibodies against the spike protein of SARS-CoV-2 were found in 98 percent of participants one month after symptom onset. As seen in previous studies, the number of antibodies ranged widely between individuals. But their levels remained fairly stable over time, declining only modestly at six to eight months after infection.

Experts point to COVID-19 vaccine as cause of virus mutation

Meanwhile, leading experts are pointing to the COVID-19 vaccine as the cause of virus mutation. (Related: Top doctor: Mass vaccination program for COVID will be ‘one of the most deadly’ in history.)

“There are clearly sources of information to suggest that once we start vaccination and we get more than 25 percent of the population vaccinated, we will allow one of the variants that’s in the background to emerge because it’s resistant to the vaccine,” board-certified internist and cardiologist Dr. Peter McCullough says.

“Just like an antibiotic, once we get to a certain percentage of coverage with an antibiotic, we’ll allow resistant bacteria to move forward.”

Dr. Geert Vanden Bossche, who has been interviewed by Bigtree on his multiplatform program “The HighWire with Del Bigtree,” offers the same explanation. Vanden Bossche says the ongoing mass vaccination drives are “likely to further enhance adaptive immune escape as none of the current vaccines will prevent replication or transmission of viral variants.”

Immune escape is a term used to describe when the host is no longer able to recognize and counter a pathogen such as a relevant variant or mutant of SARS-CoV-2.

“The more we use these vaccines for immunizing people in the midst of a pandemic, the more infectious the virus will become,” says Vanden Bossche. “With increasing infectiousness comes an increased likelihood of viral resistance to the vaccines.”

Bigtree says Vanden Bossche is not anti-vaccine. In fact, he is a seasoned vaccine developer who coordinated the Ebola vaccine program at the Global Alliance for Vaccines and Immunization (GAVI).

Dr. Robert Malone, inventor of mRNA and DNA vaccines, gives a piece of advice in line with the explanations of McCullough and Vanden Bossche. “I am reminded of the first rule of holes. When you are in one, stop digging,” Malone posts on Twitter. He has also been interviewed by Bigtree.

Former Pfizer Vice President Dr. Michael Yeadon has also appeared on Bigtree’s program. He has implored those in the medical profession to stop giving COVID-19 vaccines to people who are not at risk of dying from the virus. “Just stop giving them the vaccine. People are dying,” Yeadon says.

Bigtree notes that Vanden Bossche, Malone and Yeadon are people who have built legacies developing and promoting vaccines. “These people are destroying their historic legacy to tell us the truth. That is so rare and dangerous for them,” Bigtree says.

Watch the Sept. 23 episode of the “Health Ranger Report with Mike Adams” here:

You can catch new episodes of the “Health Ranger Report with Mike Adams” from Monday to Friday at 3-3:30 p.m. on Brighteon.TV

Follow Pandemic.news for more news and information related to the coronavirus pandemic.

Sources include:

Brighteon.com

TheEpochTimes.com

NIH.gov

LifeSiteNews.com

Dryburgh.com